Preoperative Metabolic Tumor Volume2.5 Associated with Early Systemic Metastasis in Resected Pancreatic Cancer: A Transcriptome-Wide Analysis-Reference-Cited by-同舟云学术

Preoperative Metabolic Tumor Volume2.5 Associated with Early Systemic Metastasis in Resected Pancreatic Cancer: A Transcriptome-Wide Analysis

Published:2019-05-15 Issue:3 Volume:13 Page:356-365
ISSN:1976-2283
Container-title:Gut and Liver
language:en
Short-container-title:Gut and Liver

Author:

Lee Sung Hwan¹²,Hwang Ho Kyoung²³,Lee Woo Jung²³,Yun Mijin³⁴,Kang Chang Moo²³

Affiliation:

1. Department of Systems Biology, University of Texas MD Anderson Cancer Center, Houston, TX, USA

2. Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, Yonsei University College of Medicine, Seoul, Korea

3. Pancreatobiliary Cancer Center, Yonsei Cancer Center, Severance Hospital, Seoul, Korea

4. Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Korea

Funder

Korea Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries

Publisher

The Editorial Office of Gut and Liver

Subject

Gastroenterology,Hepatology

Link

http://pdf.medrang.co.kr/GNL/2019/013/ekjg013-03-11.pdf

Reference20 articles.

1. Cancer Cell Metabolism: Warburg and Beyond

2. F-18 fluorodeoxyglucose PET in vivo evaluation of pancreatic glucose metabolism for detection of pancreatic cancer.

3. Lindholm P, Minn H, Leskinen-Kallio S, Bergman J, Ruotsalainen U, Joensuu H. Influence of the blood glucose concentration on FDG uptake in cancer: a PET study. J Nucl Med 1993;34:1-6.

4. Positron Emission Tomography Scanning: Current and Future Applications

5. Detection of Hepatic Metastases from Cancers of the Gastrointestinal Tract by Using Noninvasive Imaging Methods (US, CT, MR Imaging, PET): A Meta-Analysis

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glucose-to-Lymphocyte Ratio (GLR) as an Independent Prognostic Factor in Patients with Resected Pancreatic Ductal Adenocarcinoma—Cohort Study;Cancers;2024-05-11

2. Who could complete and benefit from the adjuvant chemotherapy regarding pancreatic ductal adenocarcinoma? A multivariate‐adjusted analysis at the pre‐adjuvant chemotherapy timing;Cancer Medicine;2022-04-17

3. MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer;Cellular Oncology;2021-11-18

4. The Role of Positron Emission Tomography in Pancreatic Cancer and Gallbladder Cancer;Seminars in Nuclear Medicine;2020-09

5. Essential updates 2018/2019: Current topics in the surgical treatment of pancreatic ductal adenocarcinoma;Annals of Gastroenterological Surgery;2020-08-09